Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983–8.

Article  CAS  PubMed  Google Scholar 

Kavousi M. Differences in epidemiology and risk factors for atrial fibrillation between women and men. Front Cardiovasc Med. 2020;7:3.

Article  PubMed  PubMed Central  Google Scholar 

Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–53.

Article  PubMed  Google Scholar 

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213–20.

Article  PubMed  PubMed Central  Google Scholar 

Mekhael M, Marrouche N, Hajjar AHE, Donnellan E. The relationship between atrial fibrillation and coronary artery disease: understanding common denominators. Trends Cardiovasc Med. 2022. https://doi.org/10.1016/j.tcm.2022.09.006.

Article  PubMed  Google Scholar 

Michniewicz E, Mlodawska E, Lopatowska P, Tomaszuk-Kazberuk A, Malyszko J. Patients with atrial fibrillation and coronary artery disease - double trouble. Adv Med Sci. 2018;63:30–5.

Article  PubMed  Google Scholar 

Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174:107–14.

Article  PubMed  PubMed Central  Google Scholar 

Aronow WS, Ahn C, Mercando AD, Epstein S. Correlation of atrial fibrillation, paroxysmal supraventricular tachycardia, and sinus rhythm with incidences of new coronary events in 1359 patients, mean age 81 years, with heart disease. Am J Cardiol. 1995;75:182–4.

Article  CAS  PubMed  Google Scholar 

Liang F, Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. Am J Physiol Heart Circ Physiol. 2021;320:H1–12.

Article  CAS  PubMed  Google Scholar 

GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2017;2018(392):1736–88.

Google Scholar 

Mahaffey KW, Stevens SR, White HD, Nessel CC, Goodman SG, Piccini JP, et al. Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. Eur Heart J. 2014;35:233–41.

Article  CAS  PubMed  Google Scholar 

Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, AFIRE Investigators, et al. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019;381:1103–13.

Article  CAS  PubMed  Google Scholar 

Kaikita K, Yasuda S, Akao M, Ako J, Matoba T, Nakamura M, et al. Bleeding and subsequent cardiovascular events and death in atrial fibrillation with stable coronary artery disease: insights from the AFIRE trial. Circ Cardiovasc Interv. 2021;14: e010476.

Article  CAS  PubMed  Google Scholar 

Zelniker TA, Ruff CT, Wiviott SD, Blanc JJ, Cappato R, Nordio F, et al. Edoxaban in atrial fibrillation patients with established coronary artery disease: insights from ENGAGE AF-TIMI 48. Eur Heart J Acute Cardiovasc Care. 2019;8:176–85.

Article  PubMed  Google Scholar 

Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, et al. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (randomized evaluation of long-term anticoagulation therapy) trial. Circulation. 2012;125:669–76.

Article  CAS  PubMed  Google Scholar 

Bahit MC, Lopes RD, Wojdyla DM, Hohnloser SH, Alexander JH, Lewis BS, et al. Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial. Int J Cardiol. 2013;170:215–20.

Article  PubMed  Google Scholar 

Masunaga N, Ogawa H, Minami K, Ishigami K, Ikeda S, Doi K, et al. Association of concomitant coronary artery disease with cardiovascular events in patients with atrial fibrillation - the Fushimi AF registry. Circ J. 2022;86:1252–62.

Article  PubMed  Google Scholar 

Abe M, Masunaga N, Ishii M, Doi K, Ishigami K, Ikeda S, et al. Current status of percutaneous coronary intervention in patients with atrial fibrillation: the Fushimi AF registry. J Cardiol. 2020;75:513–20.

Article  PubMed  Google Scholar 

Yamashita T, Suzuki S, Inoue H, Akao M, Atarashi H, Ikeda T, et al. Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the all nippon AF in the elderly (ANAFIE) registry. Eur Heart J Qual Care Clin Outcomes. 2022;8:202–13.

Article  PubMed  Google Scholar 

Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K, et al. Effect of polypharmacy on clinical outcomes in elderly patients with non-valvular atrial fibrillation- a sub-analysis of the ANAFIE registry. Circ J. 2022;87:6–16.

Article  PubMed  Google Scholar 

Akishita M, Suzuki S, Inoue H, Akao M, Atarashi H, Ikeda T, et al. Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry. Arch Gerontol Geriatr. 2022;101: 104661.

Article  PubMed  Google Scholar 

Hiasa KI, Kaku H, Kawahara G, Inoue H, Yamashita T, Akao M, et al. Echocardiographic structure and function in elderly patients with atrial fibrillation in Japan- The ANAFIE echocardiographic substudy. Circ J. 2022;86:222–32.

Article  PubMed  Google Scholar 

Okumura K, Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, et al. Oral anticoagulants in very elderly nonvalvular atrial fibrillation patients with high bleeding risks: ANAFIE registry. JACC Asia. 2022;2:720–33.

Article  PubMed  PubMed Central  Google Scholar 

Kario K, Hasebe N, Okumura K, Yamashita T, Akao M, Atarashi H, et al. Home blood pressure can predict the risk for stroke/bleeding events in elderly patients with nonvalvular atrial fibrillation from the ANAFIE registry. Hypertension. 2022;79:2696–705.

Article  CAS  PubMed  Google Scholar 

Inoue H, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the all nippon AF in the elderly (ANAFIE) registry. J Cardiol. 2018;72:300–6 ([Corrigendum in J Cardiol. 2022; 80:375–376.]).

Article  PubMed  Google Scholar 

Akao M, Ogawa H, Masunaga N, Minami K, Ishigami K, Ikeda S, et al. 10-year trends of antithrombotic therapy status and outcomes in Japanese atrial fibrillation patients - the Fushimi AF registry. Circ J. 2022;86:726–36.

Article  PubMed  Google Scholar 

Cho H, Kang J, Kim HS, Park KW. Ethnic differences in oral antithrombotic therapy. Korean Circ J. 2020;50:645–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Hoog VC, Lim SH, Bank IE, Gijsberts CM, Ibrahim IB, Kuan WS, et al. Ethnic differences in clinical outcome of patients presenting to the emergency department with chest pain. Eur Heart J Acute Cardiovasc Care. 2016;5:32–40.

Article  PubMed  Google Scholar 

Saito Y, Kobayashi Y, Tanabe K, Ikari Y. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective. Cardiovasc Interv Ther. 2020;35:19–29.

Article  CAS  PubMed  Google Scholar 

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest. 2010;137:263–72.

Article  PubMed  Google Scholar 

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk. Eur Heart J. 2019;40:2632–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown JC, Gerhardt TE, Kwon E. Risk Factors For Coronary Artery Disease. [Updated 2023 Jan 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554410/.

Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4:256.

Article  PubMed  PubMed Central  Google Scholar 

Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, et al. Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population. J Am Med Dir Assoc. 2015;16:933–9.

Article  PubMed  PubMed Central  Google Scholar 

Dalton JE, Rothberg MB, Dawson NV, Krieger NI, Zidar DA, Perzynski AT. Failure of traditional risk factors to adequately predict cardiovascular events in older populations. J Am Geriatr Soc. 2020;68:754–61.

Article  PubMed  PubMed Central  Google Scholar 

McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379:1509–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koretsune Y, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Baseline demographics and clinical characteristics in the all nippon AF in the elderly (ANAFIE) registry. Circ J. 2019;83:1538–45 ([Corrigendum in Circ J. 2020; 84:360]).

Article  PubMed  Google Scholar